Congress guts FDA drug rules—but keeps them for abortion pills
H.R. 89 — Prescription Freedom Act of 2025 · Filed by Andy Biggs (R-AZ) · Introduced Jan 3, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill repeals the FDA's federal authority to require that most drugs be dispensed only by prescription. Six months after enactment, it shifts prescription-drug regulation entirely to state law, allowing states to set their own rules on which drugs require prescriptions. The bill carves out an exception: the FDA retains its prescription authority over abortion-inducing drugs. The net effect is deregulation at the federal level and a patchwork of state-by-state rules.
Why we flagged it
The bill's operative mechanism is wholesale repeal of federal prescription authority, a deregulatory move. However, the exception preserving FDA authority over abortion-inducing drugs reveals the bill is not neutral deregulation but a targeted political maneuver to restrict access to one drug category while freeing others.
What the text implies
- State-by-state fragmentation enables regulatory arbitrage: citizens in strict states can travel to or order from permissive states, undermining local public-health policy and creating cross-border enforcement chaos.
- Removes federal oversight of compounding pharmacies and mail-order drug distribution, potentially enabling unvetted suppliers to distribute drugs without prescription verification.
The full analysis lists 5 implications of this text.
Who stands to gain
online pharmacies and mail-order drug retailers; pharmacy chains seeking to expand OTC sales; compounding pharmacies